Researchers have identified a molecular pathway involving succinate and the SUCNR1 receptor that may help prevent stem cells from turning cancerous, offering a potential new target for treating ...
Scientists report landmark "evolutionary double-bind" strategy to overcome treatment resistance in prostate cancer.
Scientists in China have unveiled a breakthrough way to mass-produce powerful cancer-fighting immune cells in the lab. By ...
Scientists at McGill University and the Rosalind and Morris Goodman Cancer Institute have developed a new way to deliver ...
Woman's World on MSN
New pancreatic cancer drug study offers major hope for treatment
In 2026, an estimated 67,530 people will be diagnosed with pancreatic cancer, according to the American Cancer Society. But imagine a treatment that could completely eliminate pancreatic cancer tumors ...
Oregon State University researchers have developed a new nanoparticle-based photothermal therapy that uses a low-power laser ...
Researchers have shared a groundbreaking development in cancer treatment research with new technology that can selectively target cancerous cells whilst sparing healthy tissue. A team at RMIT ...
The American Cancer Society’s Cancer Statistics, 2026 report highlights a historic milestone: the 5-year relative survival ...
The FDA granted breakthrough therapy designation to Rybrevant Faspro based on data from the phase 1b/2 OrigAMI-4 study (NCT06385080).
Add Yahoo as a preferred source to see more of our stories on Google. Bowel cancer remains the second most common cause of cancer death across the country, claiming around 1,700 lives annually [Getty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results